Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Predictive Clinical and Biological Parameters in Breast Cancer (BC-BIO)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Institut Paoli-Calmettes
Information provided by (Responsible Party):
Institut Paoli-Calmettes Identifier:
First received: December 22, 2011
Last updated: October 26, 2016
Last verified: October 2016

Research of predictive clinical and biological factors in breast cancer :

genomic, proteomic, mutation

Condition Intervention
Breast Cancer
Genetic: molecular alteration

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Research of Predictive Clinical and Biological Parameters in Breast Cancer

Resource links provided by NLM:

Further study details as provided by Institut Paoli-Calmettes:

Primary Outcome Measures:
  • molecular alteration in breast cancer [ Time Frame: average of 4 weeks after diagnosis ]
    gene expression level

Secondary Outcome Measures:
  • relation between molecular alteration and clinical and histological characteristics [ Time Frame: up to 3 years ]
    hazard ratio between molecular alteration and clinical and histological characteristics

Estimated Enrollment: 750
Study Start Date: December 2010
Estimated Study Completion Date: December 2026
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: breast cancer
blood and tumor sample
Genetic: molecular alteration
research of molecular alteration


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • breast cancer
  • age > 18
  • signed informed consent

Exclusion Criteria:

  • emergency
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01521676

Contact: Dominique GENRE, MD 33491223778
Contact: Jihane PAKRADOUNI, PharmD PhD 33491223778

Institut Paoli Calmettes Recruiting
Marseille, France, 13009
Contact: Carole TARPIN, MD    33491223778   
Principal Investigator: Carole TARPIN, MD         
Hôpital Sainte-Musse Recruiting
Toulon, France
Contact: Frédéric VIRET, MD   
Sponsors and Collaborators
Institut Paoli-Calmettes
Principal Investigator: Carole TARPIN, MD Institut Paoli-Calmettes
  More Information

Additional Information:
Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Institut Paoli-Calmettes Identifier: NCT01521676     History of Changes
Other Study ID Numbers: BC-BIO/IPC 2009-005
Study First Received: December 22, 2011
Last Updated: October 26, 2016

Keywords provided by Institut Paoli-Calmettes:
breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases processed this record on May 22, 2017